| Rank | Clinic Name | Patient Rating | Country | Lead Doctor | experience | Techniques | Best For | Why It’s Ranked | Accreditations |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.6 / 5 (19) | Guangzhou, China | 30+ years | Brachytherapy | Outpatient brachytherapy with no overnight hospital stay | Uses brachytherapy – radioactive seeds placed inside the tumour to spare healthy tissue – for prostate, breast, brain and liver cancers. JCI accredited. | — | ||
| #2 | 4.5 / 5 | Chengdu, China | 35+ years100,000+ treatments | Iodine-125 seed implantation, SIRT (selective internal radiation therapy), 3D treatment planning system | Recurrent or inoperable tumors treated with seed implants | — | — | ||
| #3 | — / 5 | Qionghai, China | 20+ years | CT (computer tomography), Whole-body MRI | — | — | — | ||
| #4 | 5.0 / 5 | Guangzhou, China | 20+ years | IMRT, IGRT, adaptive radiotherapy, HDR/LDR brachytherapy | — | First in China for M6 CyberKnife with real-time tumor tracking. Varian Ethos AI replans in 15 minutes daily. Six advanced systems deliver sub-millimeter precision. | Organisation of European Cancer Institutes Certificate | ||
| #5 | 4.7 / 5 (3) | Xiamen, China | 40+ years | Stereotactic body radiotherapy (SBRT), stereotactic radiosurgery (SRS), intensity-modulated radiation therapy (IMRT), 3D conformal radiotherapy, boron neutron capture therapy (BNCT) | — | First in Fujian Province with Varian VitalBeam IGRT for precise tumor targeting. Mainland China's first accelerator-based BNCT center selectively destroys cancer cells. | — | ||
| #6 | — / 5 | Shanghai, China | 23+ years | Brain MRI, Consultation with an oncologist | — | — | — | ||
| #7 | 3.0 / 5 (1) | Beijing, China | — | — | Radiotherapy | — | — | — | |
| #8 | 5.0 / 5 | Hainan Province, China | — | — | Radiotherapy | — | — | Joint Commission International | |
| #9 | 5.0 / 5 | Indonesia, China | — | — | Radiotherapy | — | — | Joint Commission International | |
| #10 | 4.0 / 5 | Guangzhou, China | 45,000+ treatments | Radiotherapy | — | — | European Society for Medical Oncology, Joint Commission International |